Concomitant antibiotic use during treatment for Clostridium difficile infection (CDI) increases the risk of recurrence. Across a network of children's hospitals, 46% of patients treated for CDI received concomitant antibiotics for a median of 7 days. Concomitant antibiotic use was more common among patients with malignancies, and solid organ or bone marrow transplant. Unnecessary concomitant antibiotic use in CDI patients is a potential target for pediatric antimicrobial stewardship.
INTRODUCTION
based largely on recommendations for the treatment of adults [2] and discontinuation of the inciting antibiotic is recommended when feasible [3] . Concomitant antibiotic use targeting other infections during treatment for CDI has been associated with a four-to five-fold increase in the risk of CDI recurrence, and should be avoided when possible [4] [5] [6] . Nearly 60% of adult patients being treated for CDI receive concomitant antibiotics [7] , but the extent to which concomitant antibiotics are prescribed during treatment for pediatric CDI is unknown. We hypothesized that rates of concomitant antibiotic use among pediatric CDI patients would be similar to those observed among adults.
METHODS

Study Design and Patient Selection
The Pediatric Health Information System (PHIS) is a database containing administrative data on billed services (including pharmacy, radiology, laboratory and other services) from 43 freestanding children's hospitals participating in the Children's Hospital Alliance (CHA). Data from the participating centers are compiled, de-identified, and validated before being released for use by researchers. We conducted a retrospective multi-center cohort study of pediatric hospitalizations using the PHIS database. Patients were eligible for inclusion if they were admitted to a PHIS hospital between greater than 99% specificity among both children [8] and adults [9] . This study has been reviewed and deemed exempt by the Institutional Review Board (IRB) of the University of Utah.
Demographic and Clinical Characteristics
Patient demographic and clinical information was collected, including age at the time of hospitalization with CDI, race, gender, presence of comorbidities based on complex chronic condition [10] , and initial CDI episode classification as presumed hospital-onset or community-onset based on the timing of anti-CDI treatment initiation [11] . Patients who initiated CDI treatment within 2 days of hospital admission were classified as community-onset, and patients who initiated CDI treatment 3 or more days following admission were classified as hospital-onset. A subgroup of immunocompromised patients including those with malignancy, solid organ, or bone marrow transplant was identified based on administrative codes. A diagnosis of cancer was based on Feudtner's complex chronic condition classification [10] . Solid organ transplant (SOT) was defined using ICD9-CM codes for lung and heart transplant (33.59, 33.6, 37.51), liver transplant (50.59), and kidney transplant (55.69). Bone marrow transplant (BMT) was defined using ICD9-CM codes for allogeneic and autologous transplant (41.00-41.03, 41.09).
Concomitant Antibiotics
Concomitant antibiotic exposure was defined as receipt of systemic antibiotics other than CDI antibiotics) for at least three consecutive days during the treatment course for CDI. This definition was chosen in order to allow for some delay in the time required to discontinue antibiotics following a CDI diagnosis. 
Data Analysis
Standard descriptive statistics (e.g., frequencies, percentages, medians) were used to characterize concomitant antibiotic use by patient subgroup and describe frequency and duration of use. All statistical analyses were conducted using SAS v.9.2 (Cary, NC, USA). [3] . The increase in risk of recurrent CDI while patients are on antibiotics is due to the continued disruption of the normal gut microbiota. Since C. difficile is ubiquitous and common in the healthcare environment, patients will remain at risk of CDI while the normal flora are suppressed. Thus, non-CDI-targeted antibiotics should not be used in the peri-infection period unless absolutely necessary.
RESULTS
Antibiotics are commonly overused, and are a major contributor to the increasing rates of drug-resistant infections [13] . Evidence suggests that 25% or more of antibiotic prescriptions across inpatient and outpatient settings are not indicated [14, 15] . However, concomitant therapy may not always be avoidable in patients with CDI. For example, management of patients with febrile neutropenia requires the initiation of empiric antibiotics to avoid severe infections [16] . Not all antibiotics may confer an increased risk of CDI or recurrent CDI [17] . 
